Regenera Activa in Singapore

Regenera Activa is an autologous micrografting treatment for hair loss. Three small 2.5 mm punch biopsies are taken from the occipital scalp, mechanically disaggregated and filtered to produce a suspension of progenitor cells, signalling factors and extracellular matrix, which is then injected into the thinning areas. Because the tissue comes from the patient, donor and recipient are the same person within one session.

No. A hair transplant moves intact follicular units from a donor area to a recipient area, and the transplanted hairs are the result. Regenera Activa does not move follicles. It introduces a cellular suspension intended to act on follicles already present in the thinning area. The two are different procedures answering different situations, and in some cases they are used alongside one another.

Female pattern hair loss is one of the presentations Regenera Activa is used for. Female pattern loss usually presents as diffuse thinning over the crown with the frontal hairline preserved, staged on the Ludwig scale, and behaves differently from male pattern loss. Suitability is decided by assessment rather than by pattern alone.

The Norwood scale is the standard classification for male pattern hair loss, running from Type I to Type VII. It describes the progression from minimal temporal recession through to loss of the bridge between the frontal and vertex regions. Staging matters because earlier stages retain more miniaturising follicles capable of responding to treatment.

The Ludwig scale classifies female pattern hair loss in three grades. Grade I is perceptible thinning over the crown with the hairline preserved; Grade II shows pronounced widening of the central parting; Grade III shows diffuse thinning with the scalp readily visible. Unlike male pattern loss, the frontal hairline is typically maintained throughout.

They are related but not identical, and the distinction is worth making because the treatment is often described loosely as a stem cell procedure. Progenitor cells are more restricted in what they can become than stem cells are. The suspension produced by micrografting contains progenitor cells alongside signalling factors and extracellular matrix. Describing it as a stem cell transplant overstates what the procedure does.

Not necessarily. Topical therapy acts on follicular perfusion and oral therapy blocks the conversion of testosterone to DHT, addressing the hormonal driver. Micrografting acts through a third route. Because androgenetic alopecia is progressive, plans commonly combine approaches rather than relying on one, and what is appropriate is decided at consultation.

Local anaesthetic is used at both the donor and recipient sites. Most patients describe pressure rather than pain. Tolerance varies between individuals, and comfort is discussed and managed during the session.

Cost depends on the extent of the area treated, the stage of hair loss identified at assessment, and whether the plan combines micrografting with medical or laser management. Because these differ between patients, a figure quoted before assessment would not be meaningful. Pricing is set out clearly at consultation.

Suitability is assessed in person. Scarring alopecia, active scalp infection or inflammation, certain autoimmune and medical conditions, bleeding disorders, and pregnancy are among the things considered. Very pronounced hair loss with few remaining follicles is also unlikely to benefit, and saying so is part of an honest assessment.

The cost of Regenera Activa in Singapore depends on the extent of the area treated, the stage identified at assessment, the consumables used, and whether micrografting is combined with medical or laser management. Dr Sin Yong gives a written quote at consultation after staging your hair loss, because the assessment decides whether treatment is advised at all. No figure is quoted beforehand.

It is worth considering for pattern hair loss at a stage where miniaturising follicles remain, in someone who wants a procedure using their own tissue and accepts that it works alongside other therapy. It is a poor fit where follicles are already lost, where the cause is not androgenetic, or where the expectation is the density a hair transplant gives.

How long any effect from Regenera Activa lasts depends on the stage and cause of hair loss, your age, medical history, how well the plan is followed, and whether other therapy continues. Androgenetic alopecia is progressive, so no duration can be promised. Review timing, and whether repeat treatment is sensible, are decided with Dr Sin Yong at consultation.

It works only on follicles that are still present, does not halt progressive hair loss outright, and is not a hair transplant. Donor-site soreness, small wounds and tenderness are expected; bleeding, infection or anaesthetic reactions are uncommon. Response varies, repeat treatment may be considered, and it usually sits alongside medical or laser management rather than replacing it.